Simplifying Hyperbilirubinemia Risk Estimation
- PMID: 33903165
- PMCID: PMC8085942
- DOI: 10.1542/peds.2020-046284
Simplifying Hyperbilirubinemia Risk Estimation
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Comment on
-
Predicting the Need for Phototherapy After Discharge.Pediatrics. 2021 May;147(5):e2020019778. doi: 10.1542/peds.2020-019778. Pediatrics. 2021. PMID: 33903163
References
-
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. [published correction appears in Pediatrics. 2004;114(4):1138]. Pediatrics. 2004;114(1):297–316 - PubMed
-
- Kuzniewicz MW, Park J, Hamid N, Walsh EM, McCulloch CE, Newman TB. Phototherapy threshold minus predischarge bilirubin predicts phototherapy after discharge. Pediatrics. 2021;147(5):e2020019778 - PubMed
-
- Hoffman K, Landman G, Clyman R, et al. ; Northern CA Neonatology Consortium. Consensus guidelines for screening & management of hyperbilirubinemia in neonates. Available at: www.phototherapyguidelines.com/. Accessed January 10, 2021
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical